Skip to main content
S 1423 112th Congress Senate

Preserving Access to Orphan Drugs Act of 2011

Official title: A bill to clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers.

Introduced: July 27, 2011 See on congress.gov
Health Health care costs and insurancePrescription drugsUser charges and fees
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 27, 2011
Read twice and referred to the Committee on Finance.
Jul 27, 2011
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 27, 2011

Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

Preserving Access to Orphan Drugs Act of 2011 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million.

Makes this Act effective as if included in PPACA.

 Related & companion bills 1
  • HR 2672 Identical bill Preserving Access to Orphan Drugs Act of 2011
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 1 Republican 2
R
Wicker, Roger F.
Mississippi · Dec 4, 2012
 R
Crapo, Mike
Idaho · Nov 13, 2012
 D
Wyden, Ron
Oregon · Jul 27, 2011
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1423: Preserving Access to Orphan Drugs Act of 2011. 112th Congress. Open America. https://openamerica.io/bill/112-S-1423/
MLA
"S. 1423: Preserving Access to Orphan Drugs Act of 2011." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-S-1423/.
Bluebook (legal)
S. 1423, 112th Cong. (2026), https://openamerica.io/bill/112-S-1423/.
Markdown link
[S. 1423: Preserving Access to Orphan Drugs Act of 2011](https://openamerica.io/bill/112-S-1423/)
Report a problem